J. Scott Garland Insider Trading $EXEL EXELIXIS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for J. Scott Garland.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of J. Scott Garland. J. Scott Garland is EVP & Chief Commerical Officer in EXELIXIS, INC. ($EXEL) and President and CEO in PORTOLA PHARMACEUTICALS INC ($PTLA) and SVP & Chief Commercial Officer in Relypsa Inc ($RLYP) and Director in Calithera Biosciences, Inc. ($CALA) and Director in Karyopharm Therapeutics Inc. ($KPTI).

J. Scott Garland in EXELIXIS, INC.

Trading Symbol: EXEL
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of J. Scott Garland: EVP & Chief Commerical Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 19 2013
$EXEL Market Capitalization: $6.19B
$EXEL Previous Close: $20.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of J. Scott Garland in EXELIXIS, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CALA, EXEL, KPTI, PTLA, RLYP

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
Sep 19 2013	EXEL	EXELIXIS, INC.	Garland J. Scott	EVP & Chief Commeri ...	Option Exercise	A	5.51	150,000	826,500	150,000
Sep 21 2012	EXEL	EXELIXIS, INC.	Garland J. Scott	EVP & Chief Commeri ...	Option Exercise	A	5.56	123,000	683,265	123,000
Oct 24 2011	EXEL	EXELIXIS, INC.	Garland J. Scott	EVP & Chief Commeri ...	Option Exercise	A	5.47	200,000	1,094,000	200,000

Page: 1